Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Jun;29(6):1215–1220. doi: 10.1128/jcm.29.6.1215-1220.1991

Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus.

M A Rahman 1, L A Kingsley 1, R W Atchison 1, S Belle 1, M C Breinig 1, M Ho 1, C R Rinaldo Jr 1
PMCID: PMC269972  PMID: 1650790

Abstract

Reactivation of Epstein-Barr virus (EBV) in early human immunodeficiency virus (HIV) infection was investigated in 49 homosexual men who seroconverted to HIV (cases) as compared with 49 matched controls who remained seronegative to HIV during a longitudinal study. EBV infection was reactivated in cases 6 months, but not 12 months, prior to HIV seroconversion as compared with controls and remained reactivated during 18 months of follow-up after HIV seroconversion, as shown by increases in immunoglobulin (Ig) G antibody titers to EBV early antigen. Antibody titers to EBV viral capsid antigen did not differ between cases and controls prior to the time of seroconversion to HIV but were significantly increased among cases by the first seropositive study visit and remained elevated during the 18 months after HIV seroconversion. Total serum IgG levels were increased in cases at the visit of seroconversion, and during 18 months of follow-up, but did not correlate with enhanced IgG production specific for EBV antigens. Significant decreases in numbers of CD4+ cells and increases in numbers of CD8+ cells during this early phase of HIV infection were not associated with changes in patterns of EBV antibody responses. Reactivation of EBV beginning 6 months before HIV seroconversion may have implications regarding the role of this herpesvirus in the pathogenesis of HIV.

Full text

PDF
1220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablashi D. V., Fladager A., Markham P. D., Salahuddin S. Z. Isolation of transforming Epstein-Barr virus from plasma of HTLV-III/LAV-infected patients. Intervirology. 1987;27(1):25–31. doi: 10.1159/000149711. [DOI] [PubMed] [Google Scholar]
  2. Alsip G. R., Ench Y., Sumaya C. V., Boswell R. N. Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis. 1988 May;157(5):1072–1076. doi: 10.1093/infdis/157.5.1072. [DOI] [PubMed] [Google Scholar]
  3. Andiman W. A., Eastman R., Martin K., Katz B. Z., Rubinstein A., Pitt J., Pahwa S., Miller G. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet. 1985 Dec 21;2(8469-70):1390–1393. doi: 10.1016/s0140-6736(85)92557-7. [DOI] [PubMed] [Google Scholar]
  4. Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med. 1986 Apr 3;314(14):874–879. doi: 10.1056/NEJM198604033141403. [DOI] [PubMed] [Google Scholar]
  5. Blumberg R. S., Paradis T. J., Crawford D., Byington R. E., Hirsch M. S., Schooley R. T. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (EBV) transformed B lymphocytes. AIDS Res Hum Retroviruses. 1987 Fall;3(3):303–315. doi: 10.1089/aid.1987.3.303. [DOI] [PubMed] [Google Scholar]
  6. Blumberg R. S., Paradis T., Byington R., Henle W., Hirsch M. S., Schooley R. T. Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Infect Dis. 1987 May;155(5):877–890. doi: 10.1093/infdis/155.5.877. [DOI] [PubMed] [Google Scholar]
  7. Breinig M. K., Zitelli B., Starzl T. E., Ho M. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis. 1987 Aug;156(2):273–279. doi: 10.1093/infdis/156.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ciobanu N., Wiernik P. H. Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virus. Mt Sinai J Med. 1986 Dec;53(8):627–638. [PubMed] [Google Scholar]
  9. Diaz-Mitoma F., Ruiz A., Flowerdew G., Houston S., Romanowski B., Kovithavongs T., Preiksaitis J., Tyrrell D. L. High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J Med Virol. 1990 Jun;31(2):69–75. doi: 10.1002/jmv.1890310202. [DOI] [PubMed] [Google Scholar]
  10. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985 Dec 19;313(25):1564–1571. doi: 10.1056/NEJM198512193132502. [DOI] [PubMed] [Google Scholar]
  11. Groopman J. E., Sullivan J. L., Mulder C., Ginsburg D., Orkin S. H., O'Hara C. J., Falchuk K., Wong-Staal F., Gallo R. C. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood. 1986 Mar;67(3):612–615. [PubMed] [Google Scholar]
  12. Henle W., Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res. 1981 Nov;41(11 Pt 1):4222–4225. [PubMed] [Google Scholar]
  13. Ho M., Miller G., Atchison R. W., Breinig M. K., Dummer J. S., Andiman W., Starzl T. E., Eastman R., Griffith B. P., Hardesty R. L. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis. 1985 Nov;152(5):876–886. doi: 10.1093/infdis/152.5.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  15. Lai P. K., Li X., Volsky D. J. Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1. Int J Cancer. 1989 Jun 15;43(6):1104–1111. doi: 10.1002/ijc.2910430625. [DOI] [PubMed] [Google Scholar]
  16. Margalith M., Sarov B., Sarov I., Rinaldo C., Detels R., Phair J., Kaslow R., Ginsberg H., Saah A. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Res Hum Retroviruses. 1990 May;6(5):607–616. doi: 10.1089/aid.1990.6.607. [DOI] [PubMed] [Google Scholar]
  17. Mizuma H., Litwin S., Zolla-Pazner S. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin Exp Immunol. 1988 Mar;71(3):410–416. [PMC free article] [PubMed] [Google Scholar]
  18. Purtilo D. T. Epstein-Barr virus: the spectrum of its manifestations in human beings. South Med J. 1987 Aug;80(8):943–947. doi: 10.1097/00007611-198708000-00003. [DOI] [PubMed] [Google Scholar]
  19. Quinlivan E. B., Holley-Guthrie E., Mar E. C., Smith M. S., Kenney S. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent. J Virol. 1990 Apr;64(4):1817–1820. doi: 10.1128/jvi.64.4.1817-1820.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Quinnan G. V., Jr, Masur H., Rook A. H., Armstrong G., Frederick W. R., Epstein J., Manischewitz J. F., Macher A. M., Jackson L., Ames J. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA. 1984 Jul 6;252(1):72–77. [PubMed] [Google Scholar]
  21. Ragona G., Sirianni M. C., Soddu S., Vercelli B., Sebastiani G., Piccoli M., Aiuti F. Evidence for disregulation in the control of Epstein-Barr virus latency in patients with AIDS-related complex. Clin Exp Immunol. 1986 Oct;66(1):17–24. [PMC free article] [PubMed] [Google Scholar]
  22. Rahman M. A., Kingsley L. A., Breinig M. K., Ho M., Armstrong J. A., Atchison R. W., Lyter D. W., Rinaldo C. R., Jr Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men. J Infect Dis. 1989 Mar;159(3):472–479. doi: 10.1093/infdis/159.3.472. [DOI] [PubMed] [Google Scholar]
  23. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  24. Rinaldo C. R., Jr, Kingsley L. A., Lyter D. W., Rabin B. S., Atchison R. W., Bodner A. J., Weiss S. H., Saxinger W. C. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J Infect Dis. 1986 Oct;154(4):556–561. doi: 10.1093/infdis/154.4.556. [DOI] [PubMed] [Google Scholar]
  25. Rinaldo C., Kingsley L., Neumann J., Reed D., Gupta P., Lyter D. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection. J Clin Microbiol. 1989 May;27(5):880–884. doi: 10.1128/jcm.27.5.880-884.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sumaya C. V., Boswell R. N., Ench Y., Kisner D. L., Hersh E. M., Reuben J. M., Mansell P. W. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis. 1986 Nov;154(5):864–870. doi: 10.1093/infdis/154.5.864. [DOI] [PubMed] [Google Scholar]
  27. Uccini S., Vitolo D., Monardo F., Faggioni A., Monarca B., Vitale A., Ruco L. P., Baroni C. D. Interaction of HIV and EBV at lymphoid tissue level: immunohistochemistry and in situ hybridization. APMIS Suppl. 1989;8:28–32. [PubMed] [Google Scholar]
  28. Wolinsky S. M., Rinaldo C. R., Kwok S., Sninsky J. J., Gupta P., Imagawa D., Farzadegan H., Jacobson L. P., Grovit K. S., Lee M. H. Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med. 1989 Dec 15;111(12):961–972. doi: 10.7326/0003-4819-111-12-961. [DOI] [PubMed] [Google Scholar]
  29. Yarchoan R., Redfield R. R., Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986 Aug;78(2):439–447. doi: 10.1172/JCI112595. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES